PubMed · 16257374
Quantitative risk modelling for new pharmaceutical compounds.
Abstract
The process of discovering and developing new drugs is long, costly and risk-laden. Faced with a wealth of newly discovered compounds, industrial scientists need to target resources carefully to discern the key attributes of a drug candidate and to make informed decisions. Here, we describe a quantitative approach to modelling the risk associated with drug development as a tool for scenario analysis concerning the probability of success of a compound as a potential pharmaceutical agent. We bring together the three strands of manufacture, clinical effectiveness and financial returns. This approach involves the application of a Bayesian Network. A simulation model is demonstrated with an implementation in MS Excel using the modelling engine Crystal Ball.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Zhengru Tang, Mark J Taylor, Paulo Lisboa, Mark Dyas. 2005-11-15. Quantitative risk modelling for new pharmaceutical compounds.. https://doi.org/10.1016/s1359-6446(05)03606-8
Cite the original work for its findings. Save a collection to share your selection of sources.